Response to chemotherapy of a radiation-induced glioblastoma multiforme. uri icon

Overview

abstract

  • BACKGROUND: Radiation-induced glioblastoma multiforme (GBM) is particularly resistant to treatment and therapeutic options are limited. We report a patient with a radiation-induced GBM who had a complete response to carmustine and survived for 44 months. PATIENTS AND METHODS: Case report of a 38-year-old man with a radiation-induced GBM that responded to carmustine. RESULTS: Our patient developed a left occipital GBM 35 years after a left cerebellar astrocytoma was treated with surgery and radiation therapy (4500 rad). The GBM was treated with subtotal resection followed by four cycles of carmustine; a complete response was achieved. He relapsed 34 months after diagnosis and with further surgery survived 44 months from his diagnosis of GBM. CONCLUSION: GBMs may be a late complication of radiation treatment for pediatric brain tumors. If further radiotherapy is not a therapeutic option, chemotherapy may result in prolonged survival.

publication date

  • May 1, 2006

Research

keywords

  • Antineoplastic Agents, Alkylating
  • Brain Neoplasms
  • Carmustine
  • Glioblastoma
  • Neoplasms, Radiation-Induced
  • Neoplasms, Second Primary

Identity

Scopus Document Identifier

  • 33646879563

Digital Object Identifier (DOI)

  • 10.1007/s11060-005-9053-5

PubMed ID

  • 16314941

Additional Document Info

volume

  • 78

issue

  • 1